Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Topaly
Rationale for Combination Therapy of Chronic Myelogenous Leukaemia With Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning
British Journal of Cancer
Cancer Research
Oncology
Related publications
Pathogenetic Rationale for Combination Therapy of Patients With Chronic Pancreatitis
Almanac of Clinical Medicine
Chronic Myelogenous Leukaemia (CML)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
Sweet's Syndrome After Splenic Irradiation for Chronic Myelogenous Leukemia
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
Oral Effects and Early Implant Survival Results After Imatinib Discontinuation Therapy for Chronic Myelogenous Leukemia: A Case Report
Clinical advances in periodontics
Periodontics
Modelling Predictors of Molecular Response to Frontline Imatinib for Patients With Chronic Myeloid Leukaemia
PLoS ONE
Multidisciplinary
Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Clinical Cancer Research
Cancer Research
Oncology
Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib
The Lancet
Medicine
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology